αV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension

Hypertension

Volumn 47, Issue 2, 2006, Pages 281-287

  Hearkens, Egidius H J ^a   Shaw, Linda ^a   Ryding, Alisdair ^b   Brooker, Gillian ^b   Mullins, John J ^b   Austin, Clare ^a   Ohanian, Vasken ^a   Heagerty, Anthony M ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Extracellular matrix; Hypertension; Hypertrophy; Integrins

Indexed keywords

BETA3 INTEGRIN; CD51 ANTIGEN; INTEGRIN; REN2 PROTEIN, MOUSE; RENIN; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTERY RESISTANCE; ARTICLE; AUTOREGULATION; BLOOD PRESSURE; BLOOD VESSEL WALL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EXTRACELLULAR MATRIX; HYPERTENSION; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG ANTAGONISM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOPRECIPITATION; MESENTERIC ARTERY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; TRANSGENIC ANIMAL; TUNICA MEDIA; VASCULAR RESISTANCE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; FLUORESCENT ANTIBODY TECHNIQUE; HYPERTENSION; IMMUNOPRECIPITATION; INTEGRIN ALPHAV; INTEGRIN ALPHAVBETA3; INTEGRINS; MESENTERIC ARTERIES; RATS; RATS, SPRAGUE-DAWLEY; RENIN; TISSUE DISTRIBUTION; TUNICA MEDIA; VASCULAR RESISTANCE;

EID: 31944444107     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000198428.45132.02     Document Type: Article

References (39)

1. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: Dual processes of remodelling and growth. Hypertension. 1993;21:391-397.
2. Sihm I, Schroeder AP, Aalkjaer C, Holm M, Morn B, Mulvany M, Thygesen K, Lederballe O. The relationship between peripheral vascular structure, left ventricular hypertrophy and ambulatory blood pressure in essential hypertension. Am J Hypertension. 1995;8:987-996.
3. Agabiti-Rosei E, Muiesan ML, Geri A, Romanelli G, Montani G, Muiesan G. Relationship between cardiac hypertrophy and forearm vascular structural changes before and during antihypertensive long-term treatment. Am J Medicine. 1988:84;125-128.
4. Christensen KL, Mulvany MJ. 1993. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vas Res. 1993;30:73-79.
5. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake and depressed excitation contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61:181-186.
6. Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertension. 1992;10:437-444.
7. Short D. Morphology of the intestinal arterioles in chronic hypertension. B Heart J. 1966;28:184-192.
8. Strauer BE. Ventricular function and coronary haemodynamics in hypertensive heart disease. Am J Cardiol. 1979;44:999-1006.
9. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension. 1993;22:523-526.
10. Martinez-Lemus, LA Hill MA, Boltz SS, Pohl U, GA Meininger. Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: implications for functional remodeling. FASEB. 2004;18:708-710.
11. Rizzoni D, Porteri E, Boari GEM, De CiuCeis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation. 2003;108:2230-2235.
12. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse ren-2 gene. Nature. 1990;344:541-544.
13. Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, Zimmermann F, Ruf p, Hilgenfeldt U, Ganten U. Species specificity of rennin kinetics in transgenic rats harbouring the human rennin and angiotensinogen genes. Proc Natl Acad Sci USA. 1992;89:7806-7810.
14. Peters J, Munter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. Increased adrenal renin in transgenic hypertensive rats, tgr(mRen2)27, and its regulation by cMAP, Angiotensin II, and Calcium. J Clin Invest. 1993;91:742-747.
15. Thybo NK, Korsgaard N, Mulvany MJ. Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension, J Hypertension. 1992;10:1191-1196.
16. Rizzoni D, Rossi GP, Porteri E, Sticchi D, Rodella L, Rezzani R, Sleiman I, De Ciuceis C, Paiardi S, Bianchi R, Nussdorfer GG, Agabiti-Rosei E. Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP. J Hypertension. 2004;22:759-766.
17. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth-muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995;96:2364-2372.
18. Clyman RI, Mauray F, Kramer RH. beta1 and beta3 Integrins have different roles in adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res. 1992;200:272-284.
19. Williams B. Mechanical influences on vascular smooth muscle cell function. J Hypertension. 1998;16:1921-1929.
20. Chicurel ME, Singer RH, Meyer CJ, Ingber DE. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature. 1998;392:730-733.
21. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid-guanidium thiocyanate-phenol-chlorophorm extraction. Analytical Biochemistry. 1987;162:156-159.
23. Siebert PD, Larrick JW. Competitive PCR. Nature. 1992;359:557-558.
24. Laemmli. 1970 Structural proteins of the head of bacteriophage T4. Nature. 1970;227:680-685.
25. Bezie Y, Lamaziere JM, Laurent S, Challande P, Cunha RS, Bonnet J, Lacolley P. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Art Thromb Vasc Biol. 1998;18:1027-1034.
26. Yang JT, Hynes RO. Fibronectin receptor functions in embryonic cells deficient in alpha(5) beta(1)-integrin can be replaced by alpha(v) integrins. Mol Biol Cell. 1996;7:1737-1748.
27. Slepian MJ, Massia SP, Dehdashti B, Fritz A, Whitesell L. beta3 integrins rather than betal integrins dominate integrin matrix interactions involved in post-injury smooth muscle cell migration. Circulation. 1998,97:1818-1827.
28. Pfaff M, Tangemann K, Muller B, Gurrath M, Muller G, Kessler H, Timpl R, Engel J. Selective recognition of cyclic RGD peptides of NMR defined conformation by alphaIIbeta3, alphaVbeta3 and alpha5beta1 Integrins. J Biol Chem. 1994;269:20233-20238.
29. Shono T, Mochizuki Y, Kanetake H, Kanda S. Inhibition of FGF-2 mediated chemotaxis of murine brain capillary endothelial cells by cyclic RGDfV peptide through blocking the redistribution of c-Src into focal adhesions. Exp Cell Res. 2001;268:169-178.
30. 3 (the vitronectin receptor). Drug Discovery Today. 2000;5:397-408.
31. Mogford JE, Davis GE, Platts SH, Meininger GA. Vascular smooth muscle alpha V beta 3 integrin mediates arteriolar vasodilatation in response to RGD peptides. Circ Res. 1996;79:821-826.
32. Vecchione C, Fratta L, Rizzoni D, Notte A, Poulet R, Porteri, Frati G, Guelfi D, Trimarco V, Mulvany MM, Agabiti-Rosei E, Trimarco B, Cotecchia S, Lembo G. Cardiovascular influences of α1b-Adrenergic receptor defect in mice. Circulation. 2002;105:1700-1707.
33. Takasaki I, Chobanian AV, Mamuya WS, Brecher P. Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension. 1992;20:20-25.
34. Wu C, Bauer IS, Juliano RL, McDonald JA. The alpha-5-Beta-1 integrin fibronectin receptor, but not the alpha-5 cytoplasmic domain functions in an early and essential step in fibronectin matrix assembly. J Biol Chem. 1993;268:21883-21888.
35. Streuli CH, Bissell MJ. Expression of extracellular-matrix components is regulated by substratum. J Cell Biol. 1990;110:1405-1415.
36. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin binding adhesion coreceptor for fibronectin. J Cell Biol. 2000;148:825-838.
37. Bakker ENTP, Buus CL, Spaan IAE, Peree I, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MI, VanBavel E. Small artery remodelling depends on tissue-type transglutaminase. Circ Res. 2005;96:119-126.
38. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertension. 2005;23:247-250.
39. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;24:3037-3043.